Icariin Attenuates Endothelial-mesenchymal Transition Via H19/miR-148b-3p/ELF5 in Ox-LDL-stimulated HUVECs
Overview
Affiliations
Atherosclerosis is the main cause of cardio-cerebrovascular diseases. Endothelial-mesenchymal transition plays an important role in atherosclerosis. Icariin has a protective effect on atherosclerosis; however, the underlying mechanism remains unclear. In this study, we explored the molecular mechanism underlying the protective function of icariin in oxidized low-density lipoprotein-stimulated human umbilical vein endothelial cells. H19, a long non-coding RNA, was identified to be downregulated in the background of the oxidized low-density lipoprotein-induced endothelial-mesenchymal transition in human umbilical vein endothelial cells. Icariin upregulated H19 expression and inhibited the transformation of endothelial cells into interstitial cells. Overexpression of H19 affected endothelial-mesenchymal transition in oxidized low-density lipoprotein-stimulated human umbilical vein endothelial cells, whereas H19 knockdown reversed endothelial protective effects of icariin and reduced human umbilical vein endothelial cell migration. Knockdown of H19 significantly downregulated oxidized low-density lipoprotein-induced E74-like factor 5 and upregulated miR-148b-3p, which was reversed by icariin. Thus, icariin may play a protective role in atherosclerosis, and H19 may be a potential therapeutic target.
Wang Y, Su Q, Tang H, Lin X, Yi Y, Tian Q Clinics (Sao Paulo). 2024; 79:100403.
PMID: 38878321 PMC: 11226750. DOI: 10.1016/j.clinsp.2024.100403.
Singh B, Cui K, Eisa-Beygi S, Zhu B, Cowan D, Shi J Vascul Pharmacol. 2024; 155:107368.
PMID: 38548093 PMC: 11303600. DOI: 10.1016/j.vph.2024.107368.
Endothelial to mesenchymal transition: at the axis of cardiovascular health and disease.
Hall I, Kishta F, Xu Y, Baker A, Kovacic J Cardiovasc Res. 2024; 120(3):223-236.
PMID: 38385523 PMC: 10939465. DOI: 10.1093/cvr/cvae021.
Luo Y, Li Y, He L, Tu H, Lin X, Zhao F Chin Med. 2023; 18(1):143.
PMID: 37919806 PMC: 10621131. DOI: 10.1186/s13020-023-00832-7.
Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition.
Yun E, Kwon B, Kim J, Lee A Anim Cells Syst (Seoul). 2023; 27(1):159-170.
PMID: 37554358 PMC: 10405771. DOI: 10.1080/19768354.2023.2244549.